Specify a stock or a cryptocurrency in the search bar to get a summary
Guobang Pharma Ltd
605507Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. Its products include quinolones, marcolides, cephalosporins, characteristic APIs, preparations and accessories, key pharmaceutical intermediates, mobile protection APIs, kinetophoretic preparations, and feed additives. The company sells its products approximately in 112 countries and regions worldwide. Guobang Pharma Ltd. was founded in 1996 and is based in Xinchang, China. Address: No. 60 Xingmei Avenue, Xinchang, China, 312500
Analytics
WallStreet Target Price
173.58 CNYP/E ratio
16.1349Dividend Yield
1.49 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 605507
Dividend Analytics 605507
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
34 %Dividend History 605507
Stock Valuation 605507
Financials 605507
Results | 2019 | Dynamics |